✦ LIBER ✦

Discovery and Structure−Activity Relationship of 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): A Highly Selective 5-Hydroxytryptamine2A Receptor Inverse Agonist for the Treatment of Arterial Thrombosis

✍ Scribed by Xiong, Yifeng; Teegarden, Bradley R.; Choi, Jin-Sun Karoline; Strah-Pleynet, Sonja; Decaire, Marc; Jayakumar, Honnappa; Dosa, Peter I.; Casper, Martin D.; Pham, Lan; Feichtinger, Konrad

Book ID: 111985922
Publisher: American Chemical Society
Year: 2010
Tongue: English
Weight: 887 KB
Volume: 53
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm100044a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and Structure−Activity Relatio

Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of Obesity

✍ Smith, Brian M.; Smith, Jeffrey M.; Tsai, James H.; Schultz, Jeffrey A.; Gilson, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 154 KB

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

Inverse agonist properties of N-(piperid

Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor

✍ Justin P. Meschler; Dennis M. Kraichely; Gerald H. Wilken; Allyn C. Howlett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 505 KB

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

Structure–Activity Relationship Study of

Structure–Activity Relationship Study of N 6 -(2-(4-(1 H -Indol-5-yl)piperazin-1-yl)ethyl)- N 6 -propyl-4,5,6,7-tetrahydrobenzo[ d ]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization

✍ Johnson, Mark; Antonio, Tamara; Reith, Maarten E. A.; Dutta, Aloke K. 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 918 KB